Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.44 is 43% above its 1-year average of 1.00, near the high end of its 1-year range (0.00–1.44).
As of the fiscal period ended Tuesday, June 30, 2026. 14.27% above its 12-month average of 1.26.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.44.
QUICK RATIO (ACID-TEST)
1.44
QUICK RATIO (ACID-TEST) AVG TTM
1.26
QUICK RATIO (ACID-TEST) AVG 3Y
N/A
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+14.27%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.07
median of 689 covered companies
CURRENT VS SECTOR MEDIAN
-53.17%
vs the sector median at left
Lumexa Imaging Holdings, Inc. Common Stock
Market Cap
$1.02B
Quick Ratio (Acid-Test)
1.44
TTM Avg
1.26
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.03B
Quick Ratio (Acid-Test)
1.98
TTM Avg
1.08
3Y Avg
1.74
5Y Avg
1.96
Market Cap
$1.01B
Quick Ratio (Acid-Test)
15.08
TTM Avg
22.50
3Y Avg
27.08
5Y Avg
27.08
Market Cap
$1.04B
Quick Ratio (Acid-Test)
5.85
TTM Avg
6.12
3Y Avg
6.56
5Y Avg
10.14
Market Cap
$1.00B
Quick Ratio (Acid-Test)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$998.79M
Quick Ratio (Acid-Test)
3.76
TTM Avg
1.39
3Y Avg
1.76
5Y Avg
2.46
Market Cap
$997.31M
Quick Ratio (Acid-Test)
5.35
TTM Avg
6.89
3Y Avg
6.87
5Y Avg
8.97
Market Cap
$997.28M
Quick Ratio (Acid-Test)
16.33
TTM Avg
11.68
3Y Avg
16.13
5Y Avg
16.13
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI) | $1.02B | 1.44 | 1.26 | N/A | N/A |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.03B | 1.98 | 1.08 | 1.74 | 1.96 |
| Immatics N.V. (IMTX)vs › | $1.03B | 7.54 | 10.49 | 6.85 | 5.34 |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $1.01B | 15.08 | 22.50 | 27.08 | 27.08 |
| Castle Biosciences, Inc. (CSTL)vs › | $1.04B | 5.85 | 6.12 | 6.56 | 10.14 |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $1.00B | N/A | N/A | N/A | N/A |
| MeiraGTx Holdings plc (MGTX)vs › | $998.79M | 3.76 | 1.39 | 1.76 | 2.46 |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $997.31M | 5.35 | 6.89 | 6.87 | 8.97 |
| Aktis Oncology, Inc. (AKTS)vs › | $997.28M | 16.33 | 11.68 | 16.13 | 16.13 |
| Pacira BioSciences, Inc. (PCRX)vs › | $991.05M | 3.94 | 2.64 | 3.04 | 2.66 |
Quick Ratio
1.44
Excludes inventory
Current Ratio
1.44
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 1.44 |
| 2026-03-31 | 1.40 |
| 2025-12-31 | 1.27 |
| 2025-09-30 | 0.92 |
| 2025-03-31 | 0.00 |
| 2024-12-31 | 0.99 |
